| Activity |
| Catalytic type | Metallo |
| Peplist | Included in the Peplist with identifier PL00198 |
| NC-IUBMB | Not yet included in IUBMB recommendations. |
| Proteolytic events | CutDB database (29 cleavages) |
| Activity status | human: active (Hughes et al., 2004) mouse: active (by similarity)
|
| Knockout | The results of experiments with a genetically modified mouse in which the catalytic domain of ADAMTS5 was deleted indicate that this peptidase is the primary "aggrecanase" responsible for aggrecan degradation in a murine model of osteoarthritis (Glasson et al., 2005). A similar conclusion was reached by Stanton et al. (2005). |
| Pharmaceutical relevance | ADAM-TS5 is a potential drug target for the treatment of osteoarthritis (Malfait et al., 2002; Glasson et al., 2005; Stanton et al., 2005). |
|
Other databases
| WIKIPEDIA | http://en.wikipedia.org/wiki/ADAMTS5 |
| Cleavage site specificity |
Explanations of how to interpret the
following cleavage site sequence logo and specificity matrix can be found here. |
| Cleavage pattern | -/-/-/e al/-/g/- (based on 435 cleavages) |